Cannarma Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Cannarma General Information

Description

Manufacturer of cannabis-based therapeutic and medicinal-grade formulation products intended to offer ayurvedic practices. The company's products include cannabis extract oil, cannabidiol (CBD) oil, hemp seed oil, and medicinal cannabis made with all-natural principles that are laboratory-tested to ensure the end users have access to a standardized, safe, and consistent product, enabling users to absorb the full phyto-cannabinoids of plants efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 69/6-A, Rama Road, Shivaji Marg
  • Industrial Area, Metro Station, Opposite Kirti Nagar
  • New Delhi, Delhi 110015
  • India
+91 093116
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Consumer Non-Durables
Personal Products
Corporate Office
  • 69/6-A, Rama Road, Shivaji Marg
  • Industrial Area, Metro Station, Opposite Kirti Nagar
  • New Delhi, Delhi 110015
  • India
+91 093116

Cannarma Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cannarma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Generating Revenue
4. Early Stage VC 17-Jul-2024 Completed Generating Revenue
3. Seed Round 25-Nov-2023 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2023 Completed Startup
To view Cannarma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cannarma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cannarma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amity Innovation Incubator Not-For-Profit Venture Capital Minority
Zero To One Fund Angel Group Minority
IIT Mandi Catalyst Accelerator/Incubator
Greenr (India) Accelerator/Incubator
To view Cannarma’s complete investors history, request access »

Cannarma FAQs

  • When was Cannarma founded?

    Cannarma was founded in 2022.

  • Where is Cannarma headquartered?

    Cannarma is headquartered in New Delhi, India.

  • What is the size of Cannarma?

    Cannarma has 11 total employees.

  • What industry is Cannarma in?

    Cannarma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Cannarma a private or public company?

    Cannarma is a Private company.

  • What is Cannarma’s current revenue?

    The current revenue for Cannarma is .

  • How much funding has Cannarma raised over time?

    Cannarma has raised $3M.

  • Who are Cannarma’s investors?

    Amity Innovation Incubator, Zero To One Fund, IIT Mandi Catalyst, and Greenr (India) have invested in Cannarma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process